For over three decades now, Ted Schroeder has worked in and around the pharmaceutical industry in the sales, marketing, and development of antibiotics. As the CEO of Nabriva Therapeutics, he has unique insights on the current development of two antibiotics which may be effective in treating community-acquired pneumonia in adults and serious urinary tract infections that do not respond to many other types of drugs.
On today’s podcast, you will learn:
Interested in learning more? Press play and visit https://www.nabriva.com/